These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 3493440

  • 21. Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.
    Berinstein N, Levy R.
    J Immunol; 1987 Aug 01; 139(3):971-6. PubMed ID: 3496394
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia: their identification, characterization and relationship to membrane IgM.
    Qian GX, Fu SM, Solanki DL, Rai KR.
    J Immunol; 1984 Dec 01; 133(6):3396-400. PubMed ID: 6333459
    [Abstract] [Full Text] [Related]

  • 26. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May 01; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H, Gavigan M, O'Malley J, Thompson D, Dadey B, Nussbaum-Blumenson A, Snider C, Rudnick S, Ferraresi R, Norred S.
    J Biol Response Mod; 1983 May 01; 2(6):499-515. PubMed ID: 6607323
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
    Buser A, Stern M, Arber C, Medinger M, Halter J, Rovo A, Favre G, Lohri A, Tichelli A, Gratwohl A.
    Bone Marrow Transplant; 2008 Oct 01; 42(7):483-7. PubMed ID: 18695668
    [Abstract] [Full Text] [Related]

  • 34. Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells.
    Maloney DG, Brown S, Czerwinski DK, Liles TM, Hart SM, Miller RA, Levy R.
    Blood; 1992 Sep 15; 80(6):1502-10. PubMed ID: 1520877
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen.
    Neelapu SS, Baskar S, Gause BL, Kobrin CB, Watson TM, Frye AR, Pennington R, Harvey L, Jaffe ES, Robb RJ, Popescu MC, Kwak LW.
    Clin Cancer Res; 2004 Dec 15; 10(24):8309-17. PubMed ID: 15623607
    [Abstract] [Full Text] [Related]

  • 39. Lymphoplasmacytic lymphoma/immunocytoma: towards a disease-targeted treatment?
    Clavio M, Quintino S, Venturino C, Ballerini F, Varaldo R, Gatto S, Galbusera V, Garrone A, Grasso R, Canepa L, Miglino M, Pierri I, Gobbi M.
    J Exp Clin Cancer Res; 2001 Sep 15; 20(3):351-8. PubMed ID: 11718214
    [Abstract] [Full Text] [Related]

  • 40. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
    Foon KA, Oseroff AR, Vaickus L, Greenberg SJ, Russell D, Bernstein Z, Pincus S, Köhler H, Seon BK, Tahaoglu E.
    Clin Cancer Res; 1995 Nov 15; 1(11):1285-94. PubMed ID: 9815923
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.